SPY423.11+2.25 0.53%
DIA339.45+0.67 0.20%
IXIC14,253.27+111.79 0.79%

Allergan Aesthetics to Acquire Soliton for $22.60 per Share

05/10/2021 05:07

09:03 AM EDT, 05/10/2021 (MT Newswires) -- Allergan Aesthetics, an AbbVie (ABBV) company, and Soliton (SOLY) said Monday they signed an agreement for Allergan to acquire Soliton, along with Resonic, its rapid acoustic pulse device, for $22.60 per share in cash.

Soliton's enterprise value for the transaction is around $550 million.

Resonic, which recently received the US Food and Drug Administration's clearance, is a noninvasive treatment for the short-term improvement in the appearance of cellulite.

The transaction is subject to customary closing conditions, including clearance by the US antitrust authorities under the Hart-Scott-Rodino Act and approval of Soliton's shareholders.

Price: 116.14, Change: +0.39, Percent Change: +0.34